Compare Amplify Seymour Cannabis ETF (CNBS) With Other Cannabis Stocks
Head-to-head stock comparisons across price, valuation, financials, and growth metrics
Amplify Seymour Cannabis ETF (CNBS)
$23.48
-0.63%
$75.3M
ETF
ETF Sector Peers
All ETF cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.
Top Matchups by Market Cap
Companies closest to Amplify Seymour Cannabis ETF in market capitalization — the most meaningful head-to-head comparisons.
Ascend Wellness Holdings
MCap: $81.1M
AFC Gamma (Advanced Flower Capital)
MCap: $67.1M
Charlotte's Web Holdings
MCap: $64.6M
GrowGeneration
MCap: $87.8M
Cannara Biotech
MCap: $92.4M
Cross-Sector Comparisons
Top cannabis companies outside the ETF sector. Compare across different business models and market segments.
Comparing CNBS in the Cannabis Market
Amplify Seymour Cannabis ETF (CNBS) is a cannabis exchange-traded fund (ETF)trading at $23.48 per share with a market capitalization of $75.3M. Among its ETF peers, CNBS ranks #3 by market cap. The stock has moved -0.63% in the current session, trading on the NYSE exchange.
When comparing CNBS against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio, revenue growth, and balance sheet strength. The comparison tables above allow you to evaluate Amplify Seymour Cannabis ETF relative to 5 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.
Frequently Asked Questions
How does CNBS compare to other ETF stocks?+
What is CNBS's biggest competitor?+
Is CNBS overvalued compared to its peers?+
Which cannabis stock has better margins than CNBS?+
Can I compare CNBS to stocks in other cannabis sectors?+
All CNBS Comparisons
Every available head-to-head comparison for Amplify Seymour Cannabis ETF.
Related Pages
Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.